DK2493493T3 - Nye bacitracinantibiotika - Google Patents

Nye bacitracinantibiotika Download PDF

Info

Publication number
DK2493493T3
DK2493493T3 DK10765613.4T DK10765613T DK2493493T3 DK 2493493 T3 DK2493493 T3 DK 2493493T3 DK 10765613 T DK10765613 T DK 10765613T DK 2493493 T3 DK2493493 T3 DK 2493493T3
Authority
DK
Denmark
Prior art keywords
bacitracin
mlz
methylene
bacitracins
lsoleucine
Prior art date
Application number
DK10765613.4T
Other languages
English (en)
Inventor
Martin Månsson
Christine Senstad
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Application granted granted Critical
Publication of DK2493493T3 publication Critical patent/DK2493493T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/03Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C07K7/58Bacitracins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (14)

1. Forbindelse repræsenteret ved formlen
hvor mindst én af Ri, R2 og R3 er -CH=CH2, og hvor Ri, R2 og R3 uafhængigt er -H, -CH3 eller -CH=CH2, og salte og hydrater deraf.
2. Forbindelse ifølge krav 1, hvor en af Ri, R2 og R3 er -CH3.
3. Forbindelse ifølge krav 1, hvor to af Ri, R2 og R3 er -CH3.
4. Forbindelse ifølge krav 1, hvor Ri er -CFRCFb.
5. Forbindelse ifølge krav 1, hvor R2 er -CFRCFb.
6. Forbindelse ifølge krav 1, hvor R3 er -CH=CFF.
7. Forbindelse ifølge krav 1, hvor Ri og R2 er -CFRCFb.
8. Forbindelse ifølge krav 1, hvor R2 og R3 er -CH=CH2.
9. Forbindelse ifølge krav 1, hvor Ri og R3 er -CFNCFb.
10. Forbindelse ifølge krav 1, hvor Ri og R2 og R3 er -CH=CH2.
11. Sammensætning, der omfatter forbindelsen ifølge krav 1.
12. Farmaceutisk sammensætning, der omfatter forbindelsen ifølge krav 1.
13. Anvendelse af forbindelsen ifølge krav 1 til fremstilling af et medikament til behandling af bakterielle infektioner.
14. Fremgangsmåde til fremstilling af forbindelser ifølge krav 1 ved substituering af isoleucin eller valin med 5-methylen-isoleucin under bacitracinsyntese in vitro.
DK10765613.4T 2009-10-28 2010-09-30 Nye bacitracinantibiotika DK2493493T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25551709P 2009-10-28 2009-10-28
PCT/EP2010/064523 WO2011051073A1 (en) 2009-10-28 2010-09-30 New bacitracin antibiotics

Publications (1)

Publication Number Publication Date
DK2493493T3 true DK2493493T3 (da) 2016-09-05

Family

ID=43417043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10765613.4T DK2493493T3 (da) 2009-10-28 2010-09-30 Nye bacitracinantibiotika

Country Status (21)

Country Link
US (1) US8410044B2 (da)
EP (1) EP2493493B1 (da)
JP (1) JP5763082B2 (da)
KR (1) KR20120097379A (da)
CN (1) CN102596218B (da)
AU (1) AU2010311762B2 (da)
BR (1) BR112012009943A2 (da)
CA (1) CA2774590A1 (da)
CY (1) CY1118233T1 (da)
DK (1) DK2493493T3 (da)
ES (1) ES2588205T3 (da)
HR (1) HRP20161020T1 (da)
HU (1) HUE029412T2 (da)
IL (1) IL219183A (da)
IN (1) IN2012DN01971A (da)
LT (1) LT2493493T (da)
PL (1) PL2493493T3 (da)
PT (1) PT2493493T (da)
RU (1) RU2536588C2 (da)
SI (1) SI2493493T1 (da)
WO (1) WO2011051073A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2493843B1 (en) 2009-10-28 2015-11-11 Xellia Pharmaceuticals ApS 2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides such as bacitracins
CN109444318B (zh) * 2018-12-03 2021-04-27 上海市食品药品检验研究院 一种用于分析杆菌肽组分的高效液相色谱方法
CN111057131A (zh) * 2019-12-13 2020-04-24 上海市食品药品检验所 一种杆菌肽及其组分的分析方法
CN111678996A (zh) * 2020-04-26 2020-09-18 上海市食品药品检验所 杆菌肽氧化组分及其分析方法和双键磺酸化半胱氨酸氧化组分的碎裂模式

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300491A (en) 1991-10-31 1994-04-05 Apothekernes Laboratorium A.S. Treatment of protozoal infection
AU3301997A (en) 1996-06-10 1998-01-07 Board Of Trustees Of The Leland Stanford Junior University Total synthesis of bacitracin polypetides

Also Published As

Publication number Publication date
KR20120097379A (ko) 2012-09-03
EP2493493A1 (en) 2012-09-05
CN102596218B (zh) 2014-10-22
IL219183A (en) 2015-04-30
CY1118233T1 (el) 2017-06-28
EP2493493B1 (en) 2016-07-06
IN2012DN01971A (da) 2015-08-21
US8410044B2 (en) 2013-04-02
CA2774590A1 (en) 2011-05-05
US20120202737A1 (en) 2012-08-09
JP2013509367A (ja) 2013-03-14
AU2010311762B2 (en) 2015-09-24
WO2011051073A1 (en) 2011-05-05
PL2493493T3 (pl) 2017-01-31
HUE029412T2 (en) 2017-02-28
PT2493493T (pt) 2016-08-31
CN102596218A (zh) 2012-07-18
LT2493493T (lt) 2016-09-26
HRP20161020T1 (hr) 2016-10-21
IL219183A0 (en) 2012-06-28
AU2010311762A1 (en) 2012-03-29
SI2493493T1 (sl) 2016-10-28
JP5763082B2 (ja) 2015-08-12
BR112012009943A2 (pt) 2019-09-24
ES2588205T3 (es) 2016-10-31
RU2536588C2 (ru) 2014-12-27
RU2012120614A (ru) 2013-12-10

Similar Documents

Publication Publication Date Title
KR20110011704A (ko) 카스포펀진 불순물 a를 함유하지 않는 카스포펀진
EP2943503B1 (en) Polymyxins, compositions, methods of making and methods of use
DK2493493T3 (da) Nye bacitracinantibiotika
JPH04217698A (ja) リポペプチド誘導体
US7285619B2 (en) Echinocandin derivatives, their method of preparation and their application as anti-fungal agents
KR101612275B1 (ko) 악티노마두라 나미비엔시스로부터 유래된 고도로 브릿징된 펩타이드
EP3111948A1 (en) New bicyclic lipopeptide, preparation and use as antimicrobial agent
Moretto et al. N‐methylation of Nα‐acylated, fully Cα‐methylated, linear, folded peptides: Synthetic and conformational aspects
EP1698638A1 (en) Lipopeptides having pharmaceutical activity
EP1204677B1 (en) Cyclohexapeptide compounds, process for their production and their use as a pharmaceutical
Reinscheid et al. The Structure of Hormaomycin and One of Its All‐Peptide Aza‐Analogues in Solution: Syntheses and Biological Activities of New Hormaomycin Analogues
DK2493843T3 (da) 2-amino-3-methyl-hex-5-ensyre og anvendelse heraf i fremstillingen af peptider, såsom bacitraciner
US20030158117A1 (en) Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals
AU2002339519B2 (en) Coniosulphides and their derivatives, method for their production and use as medicaments
EP4335861A1 (en) Antimicrobial peptoid having improved selectivity and antimicrobial composition comprising same
WO1997039025A1 (en) A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
US20040033940A1 (en) Cyclic hepta-peptide derivative from colonial ascidians, lissoclinum SP
AK et al. Toxins Workgroup Poster Abstracts: Microginin peptides from Microcystis aeruginosa